Glutathione synthesis is compromised in erythrocytes from individuals with HIV

Frontiers in Pharmacology

Volumn 5 APR, Issue , 2014, Pages

  Morris, Devin ^a   Ly, Judy ^a   Chi, Po Ting ^a   Daliva, John ^a   Nguyen, Truongson ^a   Soofer, Charleen ^a   Chen, Yung C ^a   Lagman, Minette ^a   Venketaraman, Vishwanath ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

GCL; Glutathione; GSR; GSS; HIV

Indexed keywords

GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE REDUCTASE; GLUTATHIONE SYNTHASE;

ARTICLE; CELL DAMAGE; CELL FUNCTION; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; GLUTATHIONE METABOLISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOPATHOLOGY; INNATE IMMUNITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN ANALYSIS;

EID: 84901012615     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2014.00073     Document Type: Article

References (20)

1. Choi, J., Liu, R. M., Kundu, R. K., Sangiorgi, F., Wu, W., Maxson, R., et al. (2000). Molecular mechanism of decreased glutathione content in human immunodeficiency virus type 1 Tat-transgenic mice. J. Biol. Chem. 275, 3693-3698. doi: 10.1074/jbc.275.5.3693
2. Dayaram, Y. K., Talaue, M. T., Connell, N. D., and Venketaraman, V. (2006). Characterization of a glutathione metabolic mutant of Mycobacterium tuberculosis and its resistance to glutathione and nitrosoglutathione. J. Bacteriol. 188, 1364-1372. doi: 10.1128/JB.188.4.1364-1372.2006
3. Droge, W., and Holm, E. (1997). Role of cysteine and glutathione in HIV infection and other diseases associated with muscle wasting and immunological dysfunction. FASEB J. 11, 1077-1089.
4. Fan, X., Staitieh, B. S., Jensen, J. S., Mould, K. J., Greenberg, J. A., Joshi, P. C., et al. (2013). Activating the Nrf2-mediated antioxidant response element restores barrier function in the alveolar epithelium of HIV-1 transgenic rats. Am. J. Physiol. Lung Cell. Mol. Physiol. 305, L267-L277. doi: 10.1152/ajplung.00288.2012
5. Griffith, O. W. (1999). Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic. Biol. Med. 27, 922-935. doi: 10.1016/S0891-5849(99)00176-8
6. Guerra, C., Johal, K., Morris, D., Moreno, S., Alvarado, O., Gray, D., et al. (2012). Control of Mycobacterium tuberculosis growth by activated natural killer cells. Clin. Exp. Immunol. 168, 142-152. doi: 10.1111/j.1365-2249.2011.04552.x
7. Guerra, G., Morris, D., Gray, D., Tanzil, M., Sipin, A., and Kung, S. (2011). Adaptive immune responses against Mycobacterium tuberculosis infection in healthy and HIV infected individuals. PLoS ONE 6:e28378. doi: 10.1371/journal.pone.0028378
8. Herzenberg, L. A., De Rosa, S. C., Dubs, J. G., Roederer, M., Anderson, M. T., Ela, S. W., et al. (1997). Glutathione deficiency is associated with impaired survival in HIV disease. Proc. Natl. Acad. Sci. U.S.A. 94, 1967-1972. doi: 10.1073/pnas.94.5.1967
9. Huang, C. S., Chang, L. S., Anderson, M. E., and Meister A. (1993). Catalytic and regulatory properties of the heavy subunit of rat kidney γ-glutamylcysteine synthase. J. Biol. Chem. 268, 19675-19680.
10. Levy, J. A. (1993). HIV pathogenesis and long term survival. AIDS 7, 1401-1410. doi: 10.1097/00002030-199311000-00001
11. Millman, A. C., Salman, M., Dayaram, Y. K., Connell, N. D., and Venketaraman, V. (2008). Natural killer cells, glutathione, cytokines, and innate immunity against Mycobacterium tuberculosis. J. Interferon Cytokine Res. 28, 153-165. doi: 10.1089/jir.2007.0095
12. Morris, D., Guerra, C., Donohue, C., Oh, H., Khurasany, M., and Venketaraman, V. (2012). Unveiling the mechanisms for decreased glutathione in individuals with HIV infection. Clin. Dev. Immunol. 2012:734125. doi: 10.1155/2012/734125
13. Morris, D., Guerra, C., Khurasany, M., Guilford, F., Saviola, B., Huang, Y., et al. (2013). Glutathione supplementation improves macrophage functions in HIV. J. Interferon Cytokine Res. 33, 270-279. doi: 10.1089/jir.2012.0103
14. Pantaleo, G., Graziosi, C., and Fauci, A. S. (1993). New concepts in the immunopathogenesis of human immuno deficiency infection. N. Engl. J. Med. 328, 327-335. doi: 10.1056/NEJM199302043280508
15. Sbrana, E., Paladini, A., Bramanti, E., Spinetti, M. C., and Raspi, G. (2004). Quantitation of reduced glutathione and cysteine in human immunodefiency virus-infected patients. Electrophoresis 25, 1522-1529. doi: 10.1002/elps.200305848
16. Staal, F. J. (1998). Glutathione and HIV infection: reduced reduced or increased oxidized? Eur. J. Clin. Invest. 2, 194-196. doi: 10.1046/j.1365-2362.1998.00268.x
17. Venketaraman, V., Dayaram, Y. K., Talaue, M. T., and Connell, N. D. (2005). Glutathione and nitrosoglutathione in macrophage defense against Mycobacterium tuberculosis. Infect. Immun. 73, 1886-1889. doi: 10.1128/IAI.73.3.1886-1889.2005
18. Venketaraman, V., Rodgers, T., Linares, R., Reilly, N., Swaminathan, S., Hom, D., et al. (2006). Glutathione and growth inhibition of Mycobacterium tuberculosis in healthy and HIV infected subjects. AIDS Res. Ther. 3:5. doi: 10.1186/1742-6405-3-5
19. World Health Organization. (2009). Global Tuberculosis Control: Surveillance, Planning and Financing. WHO Report (WHO/HTM/TB/2009.411). Geneva: World Health Organization.
20. World Health Organization. (2010). Towards Universal Access: Scaling up Priority HIV/AIDS Interventions in the Health Sector. Progress Report 2010. Geneva: World Health Organization.